Growth failure and outcomes in infants with biliary atresia: A report from the Biliary Atresia Research Consortium Potential conflict of interest: Dr. Shneider is on the speakers' bureau of Axcan Scandipharm. Dr. Schwarz received grants from Roche and Gilead.
Show full item record

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information

Coming Soon


MLibrary logo